Suppr超能文献

向患者传达有关炎症性肠病缓解的信息:来自美国成年患者调查的证据。

Communicating Information Regarding IBD Remission to Patients: Evidence From a Survey of Adult Patients in the United States.

作者信息

Wood Dallas W, Treiman Katherine, Rivell Aileen, van Deen Welmoed K, Heyison Hilary, Mattar Mark C, Power Sydney, Strauss Alyssa, Syal Gaurav, Zullow Samantha, Ehrlich Orna G

机构信息

RTI International, Research Triangle Park, NC, USA.

Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.

出版信息

Inflamm Bowel Dis. 2025 Jun 13;31(6):1605-1615. doi: 10.1093/ibd/izae201.

Abstract

BACKGROUND

Previous research suggests patients living with inflammatory bowel disease (IBD) understand IBD remission differently than healthcare professionals, which could influence patient expectations and clinical outcomes. We investigated 3 questions to better understand this: (1) How do patients currently understand remission; (2) Do patients currently face any barriers to communicating with their healthcare professional about remission; and (3) Can existing educational material be improved to help patients feel more prepared to discuss remission and treatment goals with their healthcare professional?

METHODS

We sent a web-based survey to adult patients with IBD in the United States. This survey included an educational experiment where patients were randomly assigned to 1 of 3 improved versions of existing educational material.

RESULTS

In total, 1495 patients with IBD completed the survey. The majority of patients (67%) agreed that remission is possible in IBD, but there was significant diversity in how they defined it with the most common being "my symptoms are reduced" (22%) and "I am no longer experiencing any symptoms" (14%). Patients reported being able to communicate openly with their healthcare professionals. Exposure to improved educational material did not have a statistically significant effect on patients' feelings of preparedness for discussing different aspects of their care with their healthcare professionals.

CONCLUSIONS

Our study confirms that patients tend to define remission in terms of resolving symptoms. We found little evidence of barriers preventing patients from discussing remission with their healthcare professionals. This suggests that educational material could be used to resolve this discrepancy in understanding.

摘要

背景

先前的研究表明,炎症性肠病(IBD)患者对IBD缓解的理解与医疗保健专业人员不同,这可能会影响患者的期望和临床结果。我们调查了三个问题以更好地理解这一点:(1)患者目前如何理解缓解;(2)患者目前在与医疗保健专业人员交流缓解情况时是否面临任何障碍;(3)现有的教育材料是否可以改进,以帮助患者更有准备地与医疗保健专业人员讨论缓解和治疗目标?

方法

我们向美国成年IBD患者发送了一项基于网络的调查。该调查包括一项教育实验,患者被随机分配到现有教育材料的三个改进版本之一。

结果

共有1495名IBD患者完成了调查。大多数患者(67%)同意IBD有可能缓解,但他们对缓解的定义存在很大差异,最常见的定义是“我的症状减轻了”(22%)和“我不再有任何症状”(14%)。患者报告能够与他们的医疗保健专业人员坦诚交流。接触改进后的教育材料对患者与医疗保健专业人员讨论其护理不同方面的准备感受没有统计学上的显著影响。

结论

我们的研究证实,患者倾向于根据症状缓解来定义缓解。我们几乎没有发现阻碍患者与医疗保健专业人员讨论缓解的障碍的证据。这表明教育材料可用于解决这种理解上的差异。

相似文献

2
Patient education interventions for the management of inflammatory bowel disease.
Cochrane Database Syst Rev. 2023 May 4;5(5):CD013854. doi: 10.1002/14651858.CD013854.pub2.
3
Residual Disease Burden Among European Patients With Inflammatory Bowel Disease: A Real-World Survey.
Inflamm Bowel Dis. 2025 Feb 6;31(2):411-424. doi: 10.1093/ibd/izae119.
7
Factors associated with chronic abdominal pain in patients with inflammatory bowel disease in remission: A pilot cross-sectional study.
Neurogastroenterol Motil. 2024 Oct;36(10):e14881. doi: 10.1111/nmo.14881. Epub 2024 Jul 30.
8
Assessment of patients' understanding of inflammatory bowel diseases: Development and validation of a questionnaire.
United European Gastroenterol J. 2022 Feb;10(1):104-114. doi: 10.1002/ueg2.12182. Epub 2021 Dec 23.
10
Communicating with patients with inflammatory bowel disease.
Inflamm Bowel Dis. 2004 Jul;10(4):444-50; discussion 451. doi: 10.1097/00054725-200407000-00020.

本文引用的文献

1
Incidence, Prevalence, and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States.
Gastroenterology. 2023 Nov;165(5):1197-1205.e2. doi: 10.1053/j.gastro.2023.07.003. Epub 2023 Jul 20.
2
Quality of Care Program Reduces Unplanned Health Care Utilization in Patients With Inflammatory Bowel Disease.
Am J Gastroenterol. 2021 Dec 1;116(12):2410-2418. doi: 10.14309/ajg.0000000000001547.
3
Prevalence of Inflammatory Bowel Disease Among Medicare Fee-For-Service Beneficiaries - United States, 2001-2018.
MMWR Morb Mortal Wkly Rep. 2021 May 14;70(19):698-701. doi: 10.15585/mmwr.mm7019a2.
7
Market share and costs of biologic therapies for inflammatory bowel disease in the USA.
Aliment Pharmacol Ther. 2018 Feb;47(3):364-370. doi: 10.1111/apt.14430. Epub 2017 Nov 22.
8
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.
Lancet. 2017 Dec 23;390(10114):2779-2789. doi: 10.1016/S0140-6736(17)32641-7. Epub 2017 Oct 31.
9
Psychometric evaluation and design of patient-centered communication measures for cancer care settings.
Patient Educ Couns. 2017 Jul;100(7):1322-1328. doi: 10.1016/j.pec.2017.02.011. Epub 2017 Feb 10.
10
Current best practice for disease activity assessment in IBD.
Nat Rev Gastroenterol Hepatol. 2016 Oct;13(10):567-79. doi: 10.1038/nrgastro.2016.128. Epub 2016 Sep 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验